Gabapentin Capsule
Product Images NDC 76420-259

9 FDA label images from Asclemed Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76420-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cockcroft And Gault Equation (Image 04)

Cockcroft And Gault Equation (Image 04)
A formula depicting the calculation for creatinine clearance (CLCr), involving age, weight, serum creatinine levels, and a factor for female patients. The formula uses weight in kilograms and serum creatinine in mg/dL values.*
FDA Label Image

Gabapentin Structural Formula (Image 05)

Gabapentin Structural Formula (Image 05)
Chemical structure diagram of the active ingredient gabapentin. The illustration shows a cyclohexane ring bonded to an amino methyl and carboxymethyl group.*
FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
A line graph depicting mean pain scores over 8 weeks comparing placebo and Gabapentin 3600 mg/day. The graph shows a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis represents mean pain scores, ranging from 0 to 10, and the x-axis represents weeks from baseline to week 8. Gabapentin shows a decline in pain scores over time, while placebo remains relatively stable.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
A line graph depicting mean pain scores over 7 weeks comparing placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks from baseline through a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Both gabapentin doses show a decrease in mean pain score over time compared to placebo.*
FDA Label Image

Figure 3 (Image 03)

Figure 3 (Image 03)
A bar graph titled 'Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) at varying doses across two studies. The y-axis represents responder proportion percentages, showing higher response rates for Gabapentin doses of 1800 mg, 2400 mg, and 3600 mg compared to placebo, with statistical significance indicated.*
FDA Label Image

Image-09 (Image 06)

Image-09 (Image 06)
A scatter plot chart showing the percentage difference on the y-axis versus daily gabapentin dose in mg on the x-axis. Data points compare three studies labeled a (black squares), b (gray squares), and c (white squares) across doses of 600 mg, 900 mg, 1200 mg, and 1800 mg, with differences increasing generally at higher doses.*
FDA Label Image

Gabapentin-100mg (Gabapentin 100mg Label)

Gabapentin-100mg (Gabapentin 100mg Label)
Label sheet displaying multiple packaging labels for Gabapentin Capsules USP 100 mg from Enovachem Pharmaceuticals. Labels show various package sizes including quantities of 30, 60, 90, 100, and 500 capsules. They include information such as the NDC numbers, manufacturer SciGen Pharmaceuticals, Inc., opaque white capsules, storage instructions, and Federal law dispensing warnings.*
FDA Label Image

Image Description (Gabapentin 300mg Label)

Image Description (Gabapentin 300mg Label)
Multiple packaging labels for Gabapentin Capsules USP 300 mg by Enovachem Pharmaceuticals, showing various NDCs and quantities ranging from 30 to 500 capsules. Labels include manufacturer ScieGen Pharmaceuticals, Inc., address for Enovachem, and standard caution statements about prescription dispensing and storage conditions. Each label features a QR code, lot and batch fields (marked as 0000000), and expiration dates where specified.*
FDA Label Image

Image Description (Gabapentin 400mg Label)

Image Description (Gabapentin 400mg Label)
This image shows multiple packaging labels for Gabapentin Capsules, USP 400 mg, manufactured by ScieGen Pharmaceuticals, Inc. and distributed by Enovachem Pharmaceuticals. Each label displays the quantity (30, 60, 90, 100, 500, 120), the NDC codes, lot number, expiration date, and a caution about prescription dispensing and storage conditions. A QR code is present on each label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.